Interleukin-21 (IL–21) was reported to manage the crosstalk between CLL cells and the surrounding microenvironment by modulating the expression of genes and miRNAs that control cell survival and proliferation. This evidence concerns the gene IL21 and B-cell chronic lymphocytic leukemia.